Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mersana Therapeutics Inc (MRSN)

Mersana Therapeutics Inc (MRSN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,015,605
  • Shares Outstanding, K 69,562
  • Annual Sales, $ 830 K
  • Annual Income, $ -88,050 K
  • 60-Month Beta 2.46
  • Price/Sales 1,260.18
  • Price/Cash Flow N/A
  • Price/Book 5.20
Trade MRSN with:

Options Overview

Details
  • Implied Volatility 53.83%
  • Historical Volatility 26.93%
  • IV Percentile 0%
  • IV Rank 1.50%
  • IV High 126.52% on 12/15/20
  • IV Low 52.72% on 06/11/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 21
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 6,333
  • Open Int (30-Day) 9,703

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.48
  • Number of Estimates 5
  • High Estimate -0.41
  • Low Estimate -0.52
  • Prior Year -0.33
  • Growth Rate Est. (year over year) -45.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.79 +5.87%
on 05/17/21
15.34 -4.82%
on 06/07/21
-0.02 (-0.14%)
since 05/14/21
3-Month
13.79 +5.87%
on 05/17/21
18.36 -20.48%
on 03/16/21
-3.44 (-19.07%)
since 03/15/21
52-Week
13.79 +5.87%
on 05/17/21
29.09 -49.81%
on 12/29/20
-6.60 (-31.13%)
since 06/15/20

Most Recent Stories

More News
New Strong Sell Stocks for May 28th

ACET, FURY, KRYS, MRSN, and NBEV have been added to the Zacks Rank #5 (Strong Sell) List on May 28, 2021

ACET : 10.97 (-6.80%)
NBEV : 2.49 (+0.81%)
KRYS : 63.40 (-2.08%)
MRSN : 14.60 (-2.67%)
FURY : 1.2300 (-3.15%)
Mersana Therapeutics to Present at Jefferies Virtual Healthcare Conference

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high...

MRSN : 14.60 (-2.67%)
Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates

Mersana Therapeutics, Inc. (MRSN) delivered earnings and revenue surprises of -28.21% and -95.60%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?...

MRSN : 14.60 (-2.67%)
Mersana Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update

- Initiated UPLIFT single-arm registration strategy for evaluation of UpRi in platinum-resistant ovarian cancer

MRSN : 14.60 (-2.67%)
Mersana Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 10, 2021 / Mersana Therapeutics, Inc. (NASDAQ:MRSN) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 10, 2021 at 4:30...

MRSN : 14.60 (-2.67%)
Mersana Therapeutics to Host Conference Call Announcing First Quarter 2021 Financial Results and Business Updates

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high...

MRSN : 14.60 (-2.67%)
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high...

MRSN : 14.60 (-2.67%)
Mersana Therapeutics Announces Appointment of Alejandra Carvajal as Senior Vice President and Chief Legal Officer

Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high...

MRSN : 14.60 (-2.67%)
Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT-1660 in Three Posters at Virtual 2021 AACR Annual Meeting

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high...

MRSN : 14.60 (-2.67%)
Thinking about buying stock in Curiositystream, Mersana Therapeutics, Energous Corp, Sogou, or SelectQuote?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CURI, MRSN, WATT, SOGO, and SLQT.

CURI : 14.37 (-4.07%)
MRSN : 14.60 (-2.67%)
WATT : 2.90 (-1.36%)
SLQT : 20.20 (-4.22%)
SOGO : 8.41 (-0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

See More

Key Turning Points

3rd Resistance Point 15.47
2nd Resistance Point 15.27
1st Resistance Point 14.93
Last Price 14.60
1st Support Level 14.39
2nd Support Level 14.19
3rd Support Level 13.85

See More

52-Week High 29.09
Fibonacci 61.8% 23.25
Fibonacci 50% 21.44
Fibonacci 38.2% 19.63
Last Price 14.60
52-Week Low 13.79

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar